M. Lević, “SIGNIFICANCE OF DETERMINATION OF LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 IN PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME”, MedPodml, vol. 74, no. 5, pp. 69–74, Feb. 2024, doi: 10.5937/mp74-39711.